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Abstract 
Aquamin is a commercially-available supplement derived from the algae species 
Lithothamnion, which has proven osteogenic potential. By harnessing this potential and 
combining Aquamin with a collagen scaffold, with architecture and composition optimised 
for bone repair, the aim of this study was to develop a natural osteo-stimulative bone graft 
substitute. A fabrication process was developed to incorporate Aquamin into scaffolds to 
produce collagen-Aquamin (CollAqua) scaffolds at two different Aquamin concentrations, 
100F or 500F (equivalent weight % of collagen or five times the weight of collagen 
respectively). CollAqua constructs had improved mechanical properties which were 
achieved without reducing the scaffold’s permeability or porosity below the minimum level 
required for successful bone tissue engineering. The fabrication process produced a 
homogenous Aquamin distribution throughout the scaffold. Release kinetics revealed that in 
the first 12 hours, the entire Aquamin content was released from the 100F however, less 
than half of Aquamin in the 500F was released with the remainder released approximately 
21 days later giving an initial burst release followed by a delayed release. Osteoblasts 
cultured on the CollAqua scaffolds showed improved osteogenesis as measured by alkaline 
phosphatase, osteopontin and osteocalcin expression. This was confirmed by increased 
mineralisation as determined by von Kossa and Alizarin red staining. 
In conclusion, a cell and growth factor free collagen-based bone graft substitute with 
enhanced mechanical properties has been developed. The addition of Aquamin to the 
collagen biomaterial significantly improved mineralisation by osteoblasts and results in a 
new product which may be capable of enhancing osteogenesis to facilitate bone repair in 
vivo. 
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Introduction 
Disease, developmental disorders, tumour resection, injury and trauma can all lead to loss, 
degeneration and damage of bone tissue. In many cases of injury, restoration of alignment 
and fixation is sufficient to induce healing and repair of the tissue.1 However, in some cases 
the defect or damage, whether pathological or trauma-induced, can be too extensive 
leading to inadequate healing. In cases such as these, bone grafting is required to provide 
mechanical support, fill osseous voids and to induce and facilitate bone repair.2 Over 2.2 
million bone-grafting procedures are undertaken worldwide annually to repair defects in 
orthopaedics, dental surgery and neurosurgery at a great socio-economic cost.3 This makes 
bone grafts second only to blood transfusions on the list of transplanted material globally. 
Collagen is a major component of the bone extra cellular matrix and is inherently 
biocompatible and biodegradable. One major problem with using collagen as the main 
constituent of a scaffold for orthopedic tissue engineering is that it has relatively poor 
mechanical properties.4 However, the Tissue Engineering Research Group in RCSI have 
demonstrated that the compressive and tensile mechanical properties of collagen and 
collagen glycosaminoglycan (collagen GAG) scaffolds, can be improved through physical and 
chemical cross-linking methods. 5,6 In addition, we have demonstrated the optimal 
composition for osteogenesis and optimal pore structure to facilitate bone tissue formation. 
7-12 Taken together, these studies have led to the development of a collagen GAG scaffold 
with an optimized composition, cross-linking density and pore size for bone regeneration 
and we have demonstrated the ability of these scaffolds to heal bone defects in vivo in 
minimally loaded calvarial defects. 13,14  
Aquamin is a commercially-available food supplement which is derived from the calcified 
skeletal remains of the red marine algae species Lithothamnion found off the coast of 
Ireland and Iceland. It is available commercially as Aqaumin F, S or soluble with calcium 
contents of approximately 31%, 17.5% and 12% respectively as well as containing 74 other 
trace minerals such as strontium, manganese, selenium, copper and zinc. Minerals from 
seawater accumulate in the fronds of the algae during its lifetime until eventually the fronds 
break off and the calcified remains are harvested and processed. The supplement does not 
contain any additives; the mineralised fronds are simply sterilized, dried and milled to 
produce the Aquamin supplements. 
While autologous bone grafting or a synthetic biomaterial are viable options for bone 
formation, often an additional stimulus is needed to enhance osteoinduction. Recent trials 
have shown that Aquamin has several positive effects on bone cells and bone health when 
taken as a supplement and when used directly on cells. Osteoblast cells cultured in the 
presence of Aquamin exhibited early osteogenic potential and produced more mineral. 15,16 
Dietary supplementation with Aquamin has been shown to preserve bone structure and 
function in mice on a high-fat Western diet (HFWD). 17 Indeed the bone structure of mice on 
a HFWD with Aquamin supplementation was superior to that of mice on the standard low 
fat diet. Thus, indicating that Aquamin supplementation has positive effects on bone health. 
In a study conducted in yearling horses, bone turnover was increased with dietary 
supplementation with Aquamin which suggests that old or damaged bone could be replaced 
or removed which could, in turn, reduce incidents of clinical bone injury. 18 Aquamin has also 
been shown both to increase the range of movement and walking distance and decrease the 
symptoms of knee osteoarthritis. 19,20 All of these results suggest that Aquamin has the 
potential to act as a supplement to enhance bone formation.  
By harnessing the osteogenic potential of Aquamin and combining it with a collagen–GAG 
scaffold with an architecture and composition optimised for bone repair, this study aimed to 
develop a natural osteo-stimulative bone graft substitute. The specific aims of this study 
were to develop a fabrication technique to incorporate Aquamin into a collagen scaffold and 
to investigate whether the incorporation of Aquamin into a collagen scaffold could produce 
a cell and growth factor free bone graft substitute with improved mechanical properties 
that could support and promote the proliferation of osteoblasts. 
 
Materials and Methods 
Scaffold Fabrication 
 
Two scaffold groups were used in the study: collagen glycosaminoglycan scaffolds and 
collagen-Aquamin scaffolds (CollAqua). Scaffolds were produced by lyophilisation of a 
collagen GAG suspension based on a previously developed protocol.5 Briefly, a suspension 
was produced by blending microfibrillar bovine tendon-derived collagen (0.5 wt%) (Integra 
Life Sciences, Plainsboro, NJ) with chondroitin-6-sulphate (0.05 wt%), isolated from shark 
cartilage (Sigma-Aldrich, Dublin, Ireland) in 2M acetic acid. CollAqua scaffolds were 
fabricated by the inclusion of Aquamin during the blending process. The three Aquamin 
variants with varying calcium concentrations (soluble, F and S) were trialled. In order to 
produce high quality scaffolds, a number of changes were made to the protocol including 
adjusting acetic acid molarity, the addition rates and order of addition. Despite these 
modifications, it was not possible to produce good quality scaffolds using Aquamin soluble 
and S and these variants were not continued. However, Aquamin F (highest calcium 
content) was successful and was added at either the equivalent weight % of collagen (100F, 
100 wt%) or five times the weight of collagen (500F, 500 wt%). 
Suspensions were maintained at 4°C during blending to prevent denaturation of the 
collagen. The suspension was lyophilised using a freezing process that was described 
previously.5 A final temperature of freezing of −10°C was used in order to produce 
homogeneous scaffolds with a mean pore size of 325 μm. 9 After freeze-drying, the scaffolds 
were cross-linked using a dehydrothermal treatment by placing the samples in an 
aluminium foil packet inside a vacuum oven (Vacucell 22; MMM) under a vacuum of 0.05 
bar at a cross-linking temperature of 105°C. 
 
Material Characteristics 
Effect of Aquamin on Mechanical Properties 
 
Compressive testing was used to determine the effect of Aquamin F on the modulus of the 
scaffolds. Mechanical testing of scaffold samples was carried out using a mechanical testing 
machine (Z050; Zwick/Roell) fitted with a 5N load cell. Samples were tested in a bath of 
phosphate buffered saline. For unconfined compression testing with impermeable, un-
lubricated platens, samples of 8mm diameter were cut from the scaffolds using a punch. 
Testing was conducted at a strain rate of 10%/min. The modulus was defined as the slope of 
a linear fit to the stress–strain curve over 2%–5% strain. 
 
Aquamin Retention in the Scaffold 
A calcium assay was used to investigate the release kinetics of Aquamin diffusion from the 
CollAqua scaffolds in an aqueous environment. Due to the high calcium concentration in the 
Aquamin F (>30%) calcium release was used as an indicator of Aquamin release. 12.5mm 
diameter scaffolds were immersed in 5ml of distilled water and the scaffolds were removed 
after 1, 5, 15, 30, 60 and 120 min and latter time points of 12, 24, 48 and 72h. 10μl of each 
sample was added in duplicate to two wells in a 96-well plate (Sarstedt, Germany) with 
100μl Total Calcium base reagent (Stanbio, USA) and 100μl Total Calcium colour reagent 
(Stanbio, USA). The absorbance was read at 570nm using a Varioskan Flash 
spectrophotometer (Thermo Scientific, USA). 
 
Aquamin Distribution in the Scaffold 
Microcomputed tomography (μCT) using a μCT-40 scanner (Scanco, Switzerland) and 
associated software was performed to obtain 3D reconstructions of scaffolds to visualise the 
Aquamin distribution within the scaffolds. Samples were divided into 209 slices and high 
resolution imaging (8μm) was used. Each scaffold was scanned three times and the images 
averaged to reduce interference. The highest energy (70kVp) and current (114μA) settings 
were used. 
 
Effect of Aquamin on Scaffold Porosity 
The porosity of each scaffold was determined using Eq. 1 below. The scaffold diameter and 
height were measured using Vernier callipers and the mass was measured, from which the 
scaffold volume and density were determined. 
Eq. 1:       
       
         
       
 
Where ρsample is the density of the sample and ρmaterial is the density of the collagen (collagen 
GAG samples) or the collagen-GAG-Aquamin composite. The value used for the bulk density 
of collagen was 1.343mg/mm3 and for Aquamin F was 0.8mg/mm3. The density for the 
collagen-Aquamin composite was calculated using Eq. 2. 
 
Eq. 2: 
        
 
     
    
 
   
   
  
 
High permeability is important as it facilitates improved cellular infiltration and 
vascularization which enhances the osteogenic potential of the host cells resulting in 
increased bone formation. 
 
Effect of Aquamin on Scaffold Permeability 
A specialised rig designed in RCSI was used to calculate the scaffold permeability. The rig 
measures the rate at which liquid passes through the scaffold and using Eq. 3 the 
permeability was calculated. 
Eq. 3:    
     
    
 
Where k is the Darcian permeability [m4/Ns], Q is the volumetric flow rate [m3/s], h is the 
height or thickness of the scaffold [m] measured before testing using digital Vernier 
callipers, μ is the viscosity of water [Pa.s], ΔP is the pressure head applied by the water 
column [Pa] and A is the cross-sectional area of the scaffold [m2] through which water flows, 
measured using digital Vernier callipers on removal of the scaffold from the rig after the 
test. 
 
Biological Characteristics 
Effect of Aquamin on Cell Attachment 
 
A cell attachment study was conducted using the pre-osteoblast MC3T3-E1 cell line. 
Collagen GAG, 100F and 500F scaffolds were placed in 6-well plates, one scaffold per well 
and 200 μl of 5 × 105 cell/ml MC3T3 suspension was seeded on each side of the scaffold 
with a 30 minute interval between each side. The seeded scaffolds were incubated for a 
further 30 minutes and each well was then flooded with 5 ml of culture media containing α- 
MEM, 10% foetal bovine serum (FBS) and 2% penicillin-streptomycin. Scaffolds were 
incubated for 1, 3 or 7 days at 37°C and 5% CO2 with a change of media after 3 days. After 
incubation, scaffolds were washed in PBS before digesting in a solution prepared from 
papain enzyme solution containing 0.5 M EDTA, cysteine-HCL and 1 mg/ml papain enzyme 
(Carica papaya, Sigma-Aldrich, Arklow, Ireland). Cell number was quantified using a Hoechst 
dye 33 258 assay which fluorescently labels double stranded DNA as previously described.9 
Measurements were taken from a fluorometric plate reader (Wallac 1420 Victor2 D, Perkin 
Elmer, MA, USA) at an emission of 460 nm and excitation of 355 nm, 1.0 s. The 
measurements were read against a standard curve to obtain the relative cell numbers per 
scaffold in terms of the DNA content. 
 
Effect of Aquamin on Osteogenic Potential and Mineralisation 
Collagen GAG, 100F and 500F scaffolds were each seeded as above and incubated for 1, 7, 
14, 21 or 28 days. Cells were cultured in culture media supplemented with 100nM 
dexamethasone, 50μM ascorbic acid and 10mM β-glycerophosphate to encourage 
mineralisation. Cell-free scaffolds were included as controls for each group. 
 
Effect of Aquamin on Alkaline Phosphatase Protein Expression 
For alkaline phosphatase (ALP) staining, scaffolds were flash frozen in liquid nitrogen before 
a lysis buffer (0.1M Sodium Acetate Buffer and 2% Triton-x-100) was added. The scaffold 
was homogenised in the buffer and left on ice before being centrifuged at 4°C for 10 mins. 
The supernatant was removed and plated with 10mM P-nitrophenyl phosphate. These were 
left in the dark for 1hr at 37°C before the reaction was stopped with sodium hydroxide 
solution. Measurements were taken from a fluorometric plate reader (Wallac 1420 Victor2 
D, Perkin Elmer, MA, USA) at 405nm absorbance. 
 
Effect of Aquamin on Osteopontin and Osteocalcin Protein Expression 
To stain for osteopontin (OPN) and osteocalcin (OCN), 10-μm sections of scaffold were 
deparaffinised as before. Slides were washed for 10 minutes x3 in washing solution (PBS, 
0.1% tween) (Sigma-Aldrich), before applying a blocking solution (PBS, 0.1% tween, 5% FBS) 
(Sigma-Aldrich) to the sections for 2 hours. Primary rabbit polyclonal IgG antibodies against 
OPN and OCN (Santa Cruz Biotechnology, USA) were applied in blocking buffer at a dilution 
of 1:250, before leaving overnight at 4°C. The next day, slides were washed as previously 
described before applying a species specific goat anti-rabbit IgG secondary antibody 
conjugated with fluorescein isothiocyanate (FITC) (Santa Cruz Biotechnology, USA) to the 
sections in the blocking buffer at a dilution of 1:250 and left in the dark at room 
temperature for 2 hours. Slides were then washed as previously described before mounting 
a cover slip using VectashieldR (Vector Laboratories Ltd., United Kingdom), which stains 
nuclei of cells with fluorescent Dapi. Images were taken using a camera (Nikon Eclipse 90i) 
and a digital imaging system (NIS Elements BR 3.0, Nikon). 
 
 
 
Effect of Aquamin on Mineralisation 
After incubation, tissue-engineered constructs were fixed in 4% paraformaldehyde for 30 
minutes. Dehydration and paraffin embedding was carried out using an automated tissue 
processor (ASP300, Leica) and blocks were cut into 10-μm sections (RM2255, Leica). All 
stained sections were taken in a horizontal plane between 25%–50% from the surface of the 
scaffold. 
To stain for calcium deposits, 10-μm sections of scaffold were deparaffinised and stained 
with 2% filtered Alizarin red (Sigma-Aldrich) solution for 2 minutes. Sections were rinsed 
with distilled H20, dehydrated in xylene and mounted with DPX (a mixture of Distyrene, a 
plasticizer, and xylene). Alizarin red stained calcium deposits were then quantified by 
applying a 10% cetylpyridinium chloride (Sigma-Aldrich) solution for 5 minutes. The leached 
stain was then collected and plated on a 96 well plate before using a plate reader (Wallac 
1420 Victor2 D, Perkin Elmer, MA, USA) at 540nm absorbance. 
To determine the presence of phosphate-based mineral, 10-μm sections of scaffold were 
deparaffinised and stained by applying 2% silver nitrate (Sigma-Aldrich) solution for 1 hour 
under bright light. The reaction was stopped by adding the developing solution, viz. 1% 
sodium thiosulphate (Sigma-Aldrich), for 1 minute. Sections were dehydrated in xylene and 
mounted with DPX. 
 
Statistics 
Statistical analysis was determined using sigma statistical software package SigmaStat 3.0. 
The statistical differences between 2 groups were calculated using the Students t test and 
multiple groups were calculated using One Way Analysis of Variance on Ranks (ANOVA). 
Statistical significance was declared at p<0.05. Results are presented as mean ± standard 
deviation. 
 
 
 
 
 
 
Results 
Scaffold Fabrication 
CollAqua slurries were initially fabricated using the standard operating procedure (SOP) for 
collagen GAG slurries 5 with one of the three Aquamin variants, soluble, F or S, gradually 
added to the slurry. However, to improve the scaffold quality a number of parameters were 
adjusted including acetic acid molarity, addition rates and methods and the order in which 
they were added. Despite modifications to the protocols, it was not possible to produce 
good quality scaffolds at the higher Aquamin soluble and Aquamin S concentrations and as a 
result, these scaffold variations were not analysed further. In contrast, Aquamin F produced 
consistently high quality scaffolds at both 100wt% (100F) and 500wt% (500F) using the 
previously described method 5 and these scaffolds were carried forward for analysis. 
 
Material Characteristics 
Effect of Aquamin on Mechanical Properties 
The mean compressive modulus for each scaffold type is shown in Fig. 1. The addition of 
Aquamin to the scaffolds resulted in significantly stiffer scaffolds at both 100F (850Pa) 
(p<0.05) and 500F (2700Pa) (p<0.05) when compared to collagen GAG alone (590Pa). The 
500F scaffold was significantly stiffer when compared to the 100F scaffold (p<0.05).  
 
Aquamin Retention in the Scaffold 
Calcium release was used as a surrogate measure of Aquamin release from the scaffold. For 
each scaffold variant the maximum dry weight of calcium was calculated in the scaffold disk 
using the physical dimensions and calcium concentration. The calcium release from each 
scaffold was expressed as a percentage of the total calcium in the scaffold disk. No calcium 
ions were measured in any aqueous samples from the collagen GAG scaffolds (Fig. 2). In 
samples from the 100F scaffolds, approximately 20% of the total calcium was released after 
just 1 minute, this increased to approximately 30% after 5 minutes. A sharp increase, to 
greater than 60% release, was seen after 15 minutes with an 80% release measured after 1 
hour. By 12 hours, all calcium within the scaffold was released. In contrast in the 500F 
scaffolds, calcium release increased from 20% after 1 minute to 40% after 15 minutes at 
which stage no additional calcium was released over the remaining 3 days. 
 
Aquamin Distribution within the Scaffold 
Aquamin distribution within the scaffolds was visualised using micro computed tomography 
(microCT). As reported in previous studies, difficulties were encountered obtaining an image 
of the collagen GAG (Fig. 3a) scaffolds due to their low density 21. The 100F scaffolds (Fig. 
3b) were also insufficiently dense to be distinguished from background noise by the 
microCT. As a result no difference was detected between the collagen GAG and 100F 
scaffold types. A much higher quality image was obtained for the denser 500F scaffold (Fig. 
3c) showing a highly uniform distribution of material throughout the scaffold. 
 
Effect of Aquamin on Scaffold Porosity and Permeability 
The results of the porosity calculations graphed in Fig. 4a show that Aquamin addition 
reduces porosity compared to collagen GAG which has a porosity of 99.4%, however 
porosity remains above 95%. The 100F scaffold was significantly less porous at 98.8% than 
the collagen GAG scaffold while the 500F scaffold (96.7%) was significantly less porous than 
both the 100F and collagen GAG scaffolds. No significant difference in permeability was 
measured between the 100F (6.7 x 10-10 m4/Ns) and 500F (6.3 x 10-10 m4/Ns) scaffolds (Fig. 
4b). Although both Aquamin scaffolds had a significantly lower permeability than collagen 
GAG (1.6 x 10-9m4/Ns), the permeability remained high indicating good pore 
interconnectivity. 
 
Biological Characteristics 
Effect of Aquamin on Cell Attachment 
Cell number was determined using the Hoescht DNA assay. Using the initial cell seeding 
density and the calculated cell number from the assay, the percentage cell attachment was 
determined. The incorporation of Aquamin into the collagen GAG scaffold had no significant 
effect on cell retention by the scaffolds. At day 1, cell attachment was approximately 50% in 
all three groups, rising to 60% and 70% at days 3 and 7 respectively (not significant). 
 
Effect of Aquamin on Alkaline Phosphatase Protein Expression 
The osteogenic potential of the scaffolds was assessed using an ALP assay. At Day 1, there 
was no significant difference in ALP levels between the scaffolds. The results showed an 
increase in the alkaline phosphatase protein in the 500F scaffold after 7 days when 
compared to the collagen GAG alone (Fig. 5). At days 21 and 28, ALP levels were significantly 
lower in 500F than both 100F and collagen GAG scaffolds. Protein levels between the 
collagen GAG and 100F scaffolds was not significantly different. 
 
Effect of Aquamin on Osteopontin and Osteocalcin Protein Expression 
Osteopontin (OPN) and osteocalcin (OCN) are non-collagenous proteins that are produced 
by osteoblasts and are routinely utilised as bone formation markers and are indicative of 
osteogenesis. The collagen GAG scaffold is known to support osteogenesis and the presence 
of both OPN and OCN were observed at day 28 in the collagen GAG scaffolds. The 
incorporation of Aquamin at 100wt% (100F) into the collagen GAG scaffolds resulted in 
higher expression of both OPN and OCN at day 28 (Fig. 6). This expression was further 
increased in the 500F scaffold where the highest expression of both proteins, but 
particularly OCN was observed. 
 
Effect of Aquamin on Mineralisation 
Fig. 7 shows qualitative mineral deposition as measured by alizarin red and Von Kossa while 
Fig. 8 shows quantification of this Alizarin Red staining. All cell-seeded scaffolds showed a  
cell mediated increase in alizarin red staining from day 1 through day 28 with the greatest 
staining visible at day 28 in all groups. Comparison between the seeded collagen GAG, 100F 
and 500F scaffolds at days 21 and 28 identifies variations in calcium deposition between the 
scaffold types. At day 21, the 500F seeded scaffold had significantly more calcium staining 
than the collagen GAG seeded scaffold. By day 28, staining in the 500F seeded scaffold had 
risen significantly to be greater than both the 100F and collagen GAG seeded scaffolds. In 
the cell-free scaffolds, collagen GAG showed no alizarin red staining. However, both the 
100F and 500F cell free controls did show an increase in alizarin red staining by day 28. 
Examination of the cell-seeded von Kossa stained scaffolds (Fig. 7) showed similar results to 
the alizarin red. Increased mineralisation was evident over time with the most staining in 
the seeded 500F scaffold at days 21 and 28. No increase in mineralisation was observed in 
the cell-free control scaffolds, the significance of which is dealt with in the discussion.  
 
 
 
Discussion 
This study describes the successful development of a bone graft scaffold incorporating the 
multi-mineral Aquamin. The development of the scaffold was technically challenging yet 
resulted in a scaffold with improved osteogenic activity and enhanced mechanical 
properties whilst maintaining optimum porosity and permeability for successful bone tissue 
engineering. Furthermore, this work adds further credence to preliminary data 15 which 
indicates the potential of Aquamin, a natural, organic, allergen free, plant-based mineral 
source to increase osteogenesis and improve bone formation.  
Aquamin addition to collagen scaffolds resulted in a significant increase in the scaffold 
mechanical properties, specifically stiffness. The 100F scaffolds were significantly stiffer 
than collagen GAG alone and the addition of 500wt% Aquamin produced a 3-fold increase in 
stiffness. This increase in stiffness makes surgical handling of scaffolds easier. However, it 
also enhances the functional maturation of osteoblasts. 22 Numerous studies have shown 
that cells respond to the stiffness of the scaffold on which they are seeded. Comparison of 
matrix stiffness has shown that cells cultured on stiffer scaffolds tend towards osteogenesis 
rather than chondrogenesis. 
The addition of Aquamin to the collagen GAG scaffold to produce the 100F and 500F 
scaffolds caused a decrease in porosity, which is important for cell infiltration and 
attachment and mass transfer of nutrients and wastes. 23 The least porous scaffold (500F) 
still achieved porosities in excess of 95%, significantly above the minimum level suggested 
to facilitate cell infiltration and for bone repair (~90%). 24 The porosity of the collagen GAG 
scaffold (99.4%) is in agreement with that reported in other studies (~99.5%). 25 Equally 
important, the permeability of the CollAqua scaffolds was such that it did not impede fluid 
flow through the scaffold demonstrating the high degree of interconnectivity of the pores 
within the scaffold. Despite the fact that the permeability of the 100F and 500F scaffolds 
was significantly less than the collagen GAG scaffold, the permeability remained within the 
range necessary for cells to penetrate the structure and for nutrients to diffuse. 11 MicroCT 
analyses confirmed that the fabrication process produced a homogenous distribution of 
Aquamin within the 500F scaffold. This distribution ensures an even release of Aquamin into 
the injury site. 
 
One of the most interesting facets of the study came when the release kinetics of the 
CollAqua scaffolds were examined. The results demonstrated that approximately 80% of the 
calcium was released from the 100F scaffold after 1 hour with the remainder being released 
over the following 11 hours. In contrast, the 500F scaffold only released approximately 40% 
of its calcium after 1 hour and no more release was observed from the scaffold for the 
remainder of the release study. The presence of the Aquamin in the 500F scaffold makes it 
available to cells at a later time, thus having the potential to enhance osteogenesis over 
time (this is discussed later). This is likely due to the fact that Aquamin F is insoluble in water 
but soluble in acid. During slurry production, 2M acetic acid is used which has the potential 
to solubilise the Aquamin. In the case of the 100F scaffold, the volume of acetic acid was 
likely sufficient to solubilise all of the Aquamin. On exposure to water the solubilised 
Aquamin was released from the scaffold. In the 100F scaffold all of the Aquamin was 
therefore released. In contrast, when fabricating the 500F slurry there may be insufficient 
acetic acid to solubilise all of the Aquamin present. Therefore the 500F scaffold instantly 
releases the solubilised Aquamin while the remaining insoluble fraction is retained and 
released more slowly from the scaffold. This type of sustained release is favourable to burst 
release in which the entire “active component” is released and subsequently degraded very 
rapidly. 
The inclusion of Aquamin in the scaffolds produced an increase in osteogenesis. This was 
initially seen as increased alkaline phosphatase expression in the 500F scaffold. ALP is a 
marker of matrix maturation and is not typically seen to express high levels in MC3T3 cells 
until much later.26 Expression usually peaks around day 21 before falling off again. However, 
in the 500F scaffold, expression reached a maximum at day 7 after which it began to fall. 
Osteopontin and osteocalcin protein expression were also enhanced by the addition of 
Aquamin. Previously it has been identified that scaffold stiffness plays a role in increasing 
osteopontin and osteocalcin expression.22, 27 Thus, the stiffer Aquamin F scaffolds may also 
play a role in aiding osteogenesis. 
We believe that the multi-mineral content in Aquamin, especially calcium, is the main 
contributor to the increased osteogenic expression. Calcium coated materials are believed 
to be good osteoinductors, as the composition of calcium aids in osteogenesis and bone 
development28. Osteoblasts can attach via N-cadherin, a calcium dependent cellular 
adhesive protein, which is an important regulator of osteoblast differentiation and 
osteogenesis. 29 The additional mineral content in Aquamin also provides an explanation for 
the higher expression of osteopontin and osteocalcin in CollAqua scaffolds, however, 
further analyses would be necessary to confirm this. 
The cell-free control scaffolds highlight some interesting results. Typically we measure 
mineralisation with alizarin red or von Kossa stain. However, alizarin red primarily stains for 
calcium which is the major constituent of Aquamin and thus a major component of the 
scaffolds. As was shown in the calcium release data, calcium is released from the Aquamin 
scaffold when it is placed in an aqueous medium. However, it was also shown that the 500F 
scaffold retained approximately 60% of its calcium. When the Alizarin red stained scaffolds 
were examined, staining in the cell-free 500F control was increased at days 21 and 28 
relative to the earlier time points. This indicates that the calcium, which was up until this 
point contained in the scaffold, was released and the Alizarin red stain can attach to it. This 
implies that we have an initial burst release of calcium within the first 2 hours which is 
followed by a delayed release of calcium after approximately 21 days. 
The highest levels of Alizarin red calcium staining were seen in the cell seeded 500F scaffold 
after 28 days. The von Kossa phosphate stain was used to determine whether this 
mineralisation was a cell mediated response or as a result of the calcium being released 
from the Aquamin scaffold. Unlike calcium, phosphates are not naturally present in 
Aquamin and they will therefore not be present in the 500F scaffold. The greatest level of 
von Kossa staining, and hence cell mediated mineral production, was in the 500F scaffold at 
days 21 and 28. Thus, confirming Aquamin’s ability to enhance osteogenesis and mineral 
production. However, we may not actually be seeing the true potential of Aquamin to 
promote osteogenesis and mineralisation in this study. During the cell culture feeds, spent 
media is removed and replaced with fresh media. Whilst this process removes waste 
material, it is also removing Aquamin which has been released from the scaffolds. 
Therefore, unlike in vivo where the Aquamin is retained in the body, in this situation the 
Aquamin is lost to the cells. An in vivo study evaluating Aquamin’s potential to enhance 
bone repair would be an interesting follow on study. 
 
Conclusions 
This study provides further data to support the use of Aquamin to enhance bone quality and 
formation as it is clear that it has a significant pro-osteogenic effect on bone cells. A cell and 
growth factor free collagen-based bone graft substitute with enhanced mechanical 
properties over a collagen-GAG scaffold has been developed. The addition of Aquamin to 
the collagen-GAG biomaterial significantly improved mineralisation by osteoblasts and 
results in a new product which may be capable of enhancing osteogenesis to facilitate bone 
repair in vivo. 
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 Figure 1: Scaffold compressive modulus (Pa) increases with the addition of Aquamin such 
that the 100F is stiffer than collagen GAG alone (*p<0.05) and the 500F is significantly stiffer 
than the 100F (#p<0.05). 
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Figure 2: Calcium release from the collagen GAG, 100F and 500F scaffolds measured over a 3 
day period. After 3 days, approximately 100% of the calcium in the 100F scaffold was 
released while only 40% was released from the 500F after the same time period. 
 
 Figure 3: Calcium distribution within the scaffolds visualised using micro computed 
tomography. No calcium can be seen in a) collagen GAG or b) 100F. In c) 500F a 
homogeneous distribution of calcium can be seen. 
 
 
 
Figure 4: (a) A significant reduction in porosity is measured in the 100F scaffold compared to 
collagen GAG alone (* p<0.05). Addition of 500wt% Aquamin produced a scaffold with a 
significantly lower porosity than both the 100F and collagen GAG scaffolds (# p<0.05) 
however porosity remained above 95%. (b) Permeability was significantly decreased after 
the addition of 100wt% Aquamin (*p<0.05). Further addition of Aquamin did not alter the 
permeability and 500F scaffolds remained less permeable than collagen GAG. 
 
 Figure 5: Alkaline phosphatase expression was significantly increased in the 500F scaffold at 
day 7 when compared to collagen GAG (*p < 0.05). At days 21 and 28 alkaline phosphatase 
expression was significantly reduced in the 500F scaffold when compared to expression in 
the collagen GAG and 100F scaffolds (# p < 0.05). 
 
Figure 6: Osteopontin and osteocalcin protein expression (blue staining) were present in the 
collagen GAG scaffold at day 28. Protein expression was increased in the 100F and 500F 
scaffolds through the addition of Aquamin F where a positive correlation was seen between 
expression and Aquamin content. 
  
Figure 7: Effect of incorporation of Aquamin into a collagen-based scaffold on osteogenesis 
as assessed by mineralisation staining with Alizarin Red and Von Kossa. Increased staining of 
Alizarin red and Von Kossa is evident at day 21 and day 28 in the 500F cell seeded scaffolds. 
Increased Alizarin red staining was seen in the 500F cell free control, however, a similar 
increase was not seen with Von Kossa staining. 
 Figure 8: Alizarin red quantification measured a significant increase in staining by day 21 in 
the 500F seeded scaffold in comparison to collagen GAG (* p<0.05). At day 28, there was 
significantly more staining present in the 500F than any other group (# p<0.001). In the cell 
free 500F control at day 28, staining was significantly greater than in either the 100F or 
collagen GAG cell free controls (** p<0.05). 
